Surface Hopping Molecular Dynamics Simulations for Photochemistry Involving Pyrene and CH₃Cl Yazar: Elham Mazarei (4508746)

Konular:

Development of immune factors over visits in the persistent and resolved CMA group as (A) scores and (B) loadings. Yazar: Diana M. Hendrickx (1507435)

Claudin-5 is involved in one of the main proteins that control the blood-brain barrier (BBB). Yazar: Zhizhong Wang (838758)

Development of immune factors over visits in the persistent and resolved CMA group as (A) scores and (B) loadings when using the persistent CMA group as a reference. Yazar: Diana M. Hendrickx (1507435)

Development of immune factors over visits in the AAF and AAF-syn treatment group as (A) scores and (B) loadings. Yazar: Diana M. Hendrickx (1507435)

Results of comparing visits within allergy groups using linear mixed models and post hoc analysis. Yazar: Diana M. Hendrickx (1507435)

Results of comparing allergy groups within visits using linear mixed models and post hoc analysis. Yazar: Diana M. Hendrickx (1507435)

Development of immune factors over visits in the AAF-syn treatment group as (A) scores and (B) loadings when using the AAF treatment group as a reference. Yazar: Diana M. Hendrickx (1507435)

Results of comparing treatment groups within visits using linear mixed models and post hoc analysis. Yazar: Diana M. Hendrickx (1507435)

Proteins with at least one significant difference (adjusted p-value ≤ 0.05) between visits within allergy groups as determined by linear mixed models and post hoc analysis. Yazar: Diana M. Hendrickx (1507435)

Results of comparing visits within treatment groups using linear mixed models and post hoc analysis. Yazar: Diana M. Hendrickx (1507435)

Proteins with at least one significant difference (adjusted p-value ≤ 0.05) between visits within treatment groups as determined by linear mixed models and post hoc analysis. Yazar: Diana M. Hendrickx (1507435)

KEGG pathways (with at least 4 measured proteins) that have at least one significant difference (adjusted p-value (q-value) ≤ 0.05) between treatment groups within visits as determ... Yazar: Diana M. Hendrickx (1507435)

Results of comparing treatment groups within visits using KEGG pathway enrichment in ConsensusPathDB. Yazar: Diana M. Hendrickx (1507435)

Results of comparing allergy groups within visits using KEGG pathway enrichment in ConsensusPathDB. Yazar: Diana M. Hendrickx (1507435)

KEGG pathways (with at least 4 measured proteins) that have at least one significant difference (adjusted p-value (q-value) ≤ 0.05) between visits within treatment groups as determ... Yazar: Diana M. Hendrickx (1507435)

Results of comparing visits within treatment groups using KEGG pathway enrichment in ConsensusPathDB. Yazar: Diana M. Hendrickx (1507435)

KEGG pathways (with at least 4 measured proteins) that have at least one significant difference (adjusted p-value (q-value) ≤ 0.05) between visits within allergy groups as determin... Yazar: Diana M. Hendrickx (1507435)

Results of comparing visits within allergy groups using KEGG pathway enrichment in ConsensusPathDB. Yazar: Diana M. Hendrickx (1507435)

Potential mechanisms for persistent CMA (left) and resolution of CMA (right) revealed by our study. Yazar: Diana M. Hendrickx (1507435)